Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

August 31, 2012

Conditions
Inflammatory Bowel Disease
Interventions
DRUG

Monofer

"* administered as intravenous infusions (A1)repeated weekly until total iron repletion is obtained~* administered as intravenous bolus injections (A2)as repeated bolus injections weekly until total iron repletion is obtained"

DRUG

Iron Sulphate

200 mg daily

Trial Locations (10)

Unknown

Research Site, Aalborg

Research Site, Aarhus

Research Site, Copenhagen

Research Site, Hyderabad

Research Site, Jaipur

Research Site, Mumbai

Research Site, Nashik

Research Site, New Delhi

Research Site, Pune

Research Site, London

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Max Neeman International

UNKNOWN

lead

Pharmacosmos A/S

INDUSTRY

NCT01017614 - Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia | Biotech Hunter | Biotech Hunter